Conférences  >  Médecine & Soins de Santé  >  Pharmacologie et développement des médicaments

Oxford Global Conferences

Engage with esteemed pharmaceutical & biotech representatives as well as thought-leaders from academic & research institutions onsite and benefit from attending over 60 presentations. We will be welcoming onsite over 300 delegates for two days of cutting-edge scientific sessions and case studies bringing the latest biologics developments to the forefront of research.

Oxford Global Conferences;     Tél.: [+44 1865 248455];     Email.: info@oxfordglobal.co.uk

Antibody-Based Molecular Engineering, Emerging Techniques for Bioanalysis & Characterisation and Quality Control Systems, Track 1: Computational Tools, AI/ML & Structural Approaches & inEngineering, Multi Specific Antibodies, Cell Engagers & Other New Modalities

The 12th Annual Pharma CI Europe Conference & Exhibition (March 30-31, 2023) is the industry's gold standard event for senior level pharma, biotech, and medical device professionals who seek the latest in competitive and business intelligence.

Event Manager;     Tél.: [+1-212-228-7974];     Email.: ross@pharmaciconference.com

Cambridge healthtech Institute

Final Agenda Now Available Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent tracks. New for 2023 is coverage of targeting transcription factors, plus greatly expanded coverage of protein degraders, molecular glues, and artificial intelligence for early drug discovery. Speakers from industry will once again be strongly represented, including: AbbVie, Amgen, Astex Pharmaceuticals, AstraZeneca, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, GlaxoSmithKline, Janssen, Johnson & Johnson, Merck, Novartis, Pfizer, and more. In addition, featured presentations will be given by the University of Washington's David Baker, Stanford's Gerald Crabtree, Vanderbilt's Stephen Fesik, and UC Berkeley's Daniel Nomura. For maximum savings, reserve your place by March 3. Bring a team to San Diego and save 25% with a Group registration

Cambridge healthtech Institute;     Tél.: [7819725400];     Email.: reg@healthtech.com

Academic Research, Analytical Research, Biochemical, Bioengineering, Bioethics, Bioinformatic, Biological Science, Biomedicine, Bioprocessing, Biosciences, Biotech, Biotechnology, Chemical, Chemistry, Discovery, Doctors, Drug, Education, Education & Elearning, Expo, General Science, Physics & Chemistry, Health, Health & Medicine, Healthcare, Leadership, Leadership & Innovation, Learning, Lecturers, Lectures, Life Sciences, Medical, Medical Science, Medicine, Pharma, Pharmaceutical, Pharmaceuticals, Pharmaceutics, Pharmacology, Pharmacovigilance, Pharmacy, Research, research symposium, Researchers, Science, Science and Technology, Scientific, Scientists, Technology, Virtual Conference,

Oxford Global

Consisting of the Pharmaceutical Mobile Robotics Congress and SmartLabs Automation Congress, visionary leaders will discuss the current state of the industry, market trends and future growth areas pushing the pharma automation industry in the future. Join leaders, experts and researchers at Pharma Automation and Robotics UK and discuss digital QA/QC labs, accelerating digital transformation, lab robotics & tools for drug discovery workflows, robotic process automation and implementing AI/ML in the lab. Automation of pharma manufacturing and the application of mobile robotics in QA/QC labs will also be discussed.

Oxford Global;     Tél.: [+441865248455];     Email.: info@oxfordglobal.co.uk

pharma automation, robotics, laboratories, drug development, bio banking, drug screening, lab analysis

Optica

Focuses on the convergence in these rapidly evolving areas, spanning from basic biology to clinical diagnostics and therapeutic applications. This multidisciplinary topical meeting will highlight recent advances in these rapidly evolving areas with a goal of stimulating novel strategies for molecular probe development, site-specific drug delivery, monitoring treatment response and clinical translation to improve diagnosis or treatment of diseases. Areas to be covered include, but are not limited to, novel molecular probe design, applications of smart molecular probes in basic and applied research, endogenous and exogenous optical molecular biomarkers, multimodal imaging, advances in instrumentation and algorithms for optical molecular imaging, molecular and functional imaging of normal and diseased tissue, image-guided drug delivery, drug screening and monitoring therapeutic response.

Opto-électronique et technique d'affichage,    Génie biomédical

Royal Society of Chemistry (RSC)

With more than 70 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 10th SCI/RSC symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.

Oxford Global Conferences

Our CGT Manufacturing & Supply Chain Congress facilitates high-level discussion to streamline and fast-track the manufacture, development, and commercialisation of advanced therapy medicinal products.

Tél.: [+44 1865 248455];     Email.: h.liddiard@oxfordglobal.co.uk

Cell, Gene Therapy, Biopressing, Viral Vector Production, Cryopreservation, cGMP Manufacturing, Single-use Technologies

Bioprocess solutions to achieve sustainable development goals; Approaches for enabling a circular economy; Novel bioprocesses as a driver for bioeconomy; Sustainability in biopharma processes; Smart bioreactor and Downstream processing concepts

Génie chimique,    Chimie industrielle et chimie verte

FDAMap

​Clinical trials are highly regulated multi-dimensional projects that require constant interactions between the regulators and the sponsors, investigators, other personnel, and even patients involved in the conduct of a given trial. There are many diverse tasks involved in the conduct of a clinical trial starting from the development of a clinical trial protocol, finding and starting clinical trial sites, filing of an IND or IDE application, approvals from IRBs, numerous documents need to be collected to demonstrate compliance with regulations; managing supplies, collecting data, writing reports, and many other things. Clinical project managers need to understand, implement, and trouble-shoot practically all aspects of the clinical trial under them. Clinical project managers have to build teams and have clear perspective of what may be needed for assuring compliance with FDA requirements of a given clinical trial at all times. This one-of-a-kind program will train you in regulatory affairs, clinical operations, monitoring, patient recruitment and retention, planning, medical writing, safety monitoring and practically all major aspects of running a clinical trial.

#FDA #Clinical Trials #Clinical Studies #Clinical Research #Clinical Operations #Clinical Development #Clinical Trial Protocol #Clinical Project Management #Clinical Trial Sites #Clinical Project Managers #FDA Compliance #FDA Regulation

Législation en médecine et pharmacologie,    Médecine translationnelle, essais cliniques

Oxford Global

Learn from and meet leading experts in pharmaceutical science, addressing the critical strategic advances and technical innovation in formulation, drug delivery and drug product development.

Oxford Global;     Tél.: [+441865248455];     Email.: l.ahmed@oxfordglobal.co.uk

Formulation, Drug Delivery, Drug Product Development, Therapeutic Modalities

Scientific Update Ltd.

The aim of this course is to provide attendees with a good basis to work from when involved in taking development candidates to the first in human trials with a view also on some longer-term requirements.  The course content will therefore focus on the necessary early phases of chemical development as would typically be required to support production of up to about 2kg using laboratory-based 20L equipment and pilot plant equipment.

Formation professionnelle continue en chimie,    Biochimie et chimie médicale, toxicologie

Oxford Global

Join and network with over 400 industry leaders at the renowned Drug Discovery Summit in Berlin, where we will address the latest advancements in target identification, validation and HIT optimisation.

Oxford Global;     Tél.: [+441865248455];     Email.: h.liddiard@oxfordglobal.co.uk

Phenotypic, Medicinal Chemistry, Novel Targets, Disease Modelling, Chip Development, Genomic Strategies, Chemical Biology, Drug Design, Chemical Modalities

The meeting will explore bacterial pathogens and pathogenesis from multiple perspectives, from cellular mechanisms to interbacterial interactions and community behavior, as well as pathogenesis in the complex milieu of the microbiota. The meeting will also highlight the pathogenic potential of the microbiome and explore microbiota-based and engineered antibacterial/therapeutic approaches.

Maladies Infectieuses,    Biologie

Oxford Global Conferences

Across four in-depth sessions the latest improvements pushing the industry forward will be addressed: from stability & clinical manufacturing, RNA computational design approaches, through to case studies & recent developments in RNA delivery platforms. Stay at the forefront of the growing interest in this area and hear case studies from the applications of RNAs in therapeutics and delivery challenges & future opportunities.

Tél.: [+44 1865 248455];     Email.: l.ahmed@oxfordglobal.co.uk

RNA Formation, mRNA vaccine formulation development, Advances in mRNA technology, Tissue & cell targeting, Developing RNA technologies, Cardiovascular diseases, Oncology, Infectious & viral diseases, Neurodegenerative diseases, Pulmonary diseases, Genetic disorders & medicines

For many years, nucleos(t)ide analogues and nucleic acids have served as cornerstones of drug design and development efforts. The Nucleosides, Nucleotides and Oligonucleotides (NNO) Gordon Research Conference is dedicated to understanding the fundamental chemistry, biology, and technologies for the diagnosis and treatment of various diseases using nucleos(t)ides and nucleic acid analogues. In recent years nucleic acids have seen wide use in chemical biology investigations as well as in the clinic as therapeutics and diagnostics. Emerging areas like CRISPR gene editing and siRNA have been developed due to the extensive efforts of many in the NNO field. The 2023 edition will be the 21st NNO GRC and will reflect the evolution of the field and the current explosive growth of NNO based therapeutics, from its original focus on purine and pyrimidine chemistry and biology, to the much broader current scope.

Chemical Biology of Nucleosides and Nucleic Acids Towards Human Therapeutics

Biologie moléculaire,    Biochimie et chimie médicale, toxicologie

Scientific Update Ltd.

Participants will learn how to identify and prioritise process parameters, determine and manage risk, and implement control strategies. The use of experimental design (DoE) in QbD, the identification of potential mixing and scale-up problems, and the safe scale up of processes to pilot and manufacturing plants will also be discussed.

Formation professionnelle continue en chimie,    Génie chimique

Oxford Global Conferences

An intensive 2-day meeting that delves into the latest in antibody engineering and antibody-based therapeutics & a meeting place for experts working within engineering, computational tools and antibody-based therapeutics.

Tél.: [+44 1865 248455];     Email.: h.liddiard@oxfordglobal.co.uk

Engineering of antibodies, designing new and required antibodies, Fc engineering, assessing target specificity, transforming targets for antibody-based therapeutics

Oxford Global Conferences

An intensive 2-day meeting that delves into the latest in advancements in FAIR data, data analytics, AI and machine learning technologies in pharma, as well as latest advancements in the adoption of innovative & digital health technologies, high-performance medicine and digital biomarkers

Oxford Global Conferences;     Tél.: [+44 1865 248455];     Email.: h.liddiard@oxfordglobal.co.uk

PharmaTec, Digital Medicine, Data Analytics, AI, Digital Health Technologies, Data Automation, Computational Biology Applications, Digital Health, Digital Therapeutics, Precision Medicine, Digital Biomarkers

Oxford Global Conferences

Connecting global academic & research organisations as well as pharma representatives for high-level discussions on the latest innovations in spatial research & technologies.

Oxford Global Conferences;     Tél.: [+44 1865 248455];     Email.: d.dalby@oxfordglobal.co.uk

Spatial Biology, Oncology, Cardiovascular Diseases, Drug Discovery & Development, Personalised Medicine, Biomarkers, Spatial Data Analysis, Toxicology

Biologie,    Cancérologie

ipharma Expo

iPharma Expo 2023, USA (International Pharmaceutical Business Expo 2023) scheduled during September 21-22, 2023, at San Francisco, U.S.A. This expo will showcase the latest trends and technologies in pharmaceuticals, drugs and formulations and will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries.

Email.: anna@ipharmaexpo.net

Pharma Expo, pharma congress, pharma Expo USA, pharmaceutical event, pharma USA, pharmaceutical expo, international pharma, iPharma USA, Pharma USA, iPharma 2023, pharma event USA, pharma business USA, iPharma register, pharma abstract, Drug Discovery, Drug Delivery Systems, Pharmaceutical Nanotechnology, Drug Therapy, Pharmaceutical Formulations, Clinical Trials, Neuropharmacology, Biopharmaceutical, Nutraceuticals, Pharma Medicines

Uventia Global

Highly potent active pharmaceutical ingredients, or HPAPIs, are potent compounds that could effectively treat serious and life-threatening diseases such as cancer. Because of their high potency, these substances eventually put the workers in the production facility at risk. While exceptional product quality is required, additional measures must be taken to ensure operator safety. At our online meeting, leading figures from the industry, occupational toxicologists and containment specialists will review the most recent developments affecting the handling of HPAPIs. The discussion will center on the safe and effective processing of potent APIs, process development and scale-up, occupational health hazards, toxicological assessment, improvements in isolators and facilities to minimize exposure risk, containment and cleaning validation practices, and risk management for cross-contamination.

Email.: yuliia.terletska@uventia.com

HPAPI, API, Compounds Manufacturing, Occupational Toxicology, Industrial Hygiene, Process Engineering, Process Development, Containment, Cross Contamination, Cleaning Validation, Cleanroom, Risk Management, Quality Assurance, Quality Control, Analytical Development, Analytical Methods, Outsourcing

Biochimie et chimie médicale, toxicologie ,    Biotechnologie

Infonet

5th International Pharmaceutical Conference and Expo welcomes you as our guest to the City of Baltimore, USA during October 05-06, 2023. The theme of the upcoming edition of iPharma USA is Bridging Pharma Research with Industry.

Tél.: [6193784793];     Email.: anna@ipharmaconference.net

Pharma conference, pharmaceutical event, pharma congress, pharma expo, pharma conference USA, pharmaceutical event, pharma USA, pharmaceutical expo, international pharma, iPharma USA, Pharma USA, iPharma 2023, pharma conference USA, pharma event USA, pharma event USA, pharma business USA, iPharma register, pharma abstract, Drug Discovery, Drug Delivery Systems, Pharmaceutical Nanotechnology, Drug Therapy, Pharmaceutical Formulations, Clinical Trials, Neuropharmacology, Biopharmaceutical, Nutraceuticals, Pharma Medicines

Oxford Global Conferences

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

Oxford Global Conferences;     Tél.: [+44 1865 248455];     Email.: b.westmore@oxfordglobal.co.uk

Biomarkers, Personalised Medicine, Oncology, Infectious Disorders, Imaging Technologies, Digital Pathology, Flow Cytometry, Immunoassays, Genomic Markers, Precision Medicine

SPhERe addresses major issues on innovative methods and processes to develop and manufacture effective and customized drugs in a cost-efficient manner. Bringing together pharmacists, process and production engineers as well as microtechnologists from academia and industry, the conference will promote multidisciplinary exchange and collaboration.

API Sythesis, Scale-Up Processes, Scale-Down Processes, Solid, Semi-Solid & Liquid Dosage Forms, Digital Models in Pharmaceutical Manufacturing, Analytics, Process Analytical Technology (PAT), Microsystems for Pharmaceutical Testing

Scientific Update Ltd.

This 2½ day course aims to give chemists and chemical engineers a thorough practical knowledge of crystallisation processes. After an introduction the course will cover crystallisation of compounds (including hydrates and solvates), different methods of crystallisation, polymorphism, salts and co-crystals, crystallisation of chiral compounds and classical resolution, analytical methods for studying the solid state and will finish with some case studies. Real life practical examples will be used throughout the course to exemplify the different aspects of crystallisation and polymorphism. The course will cover all aspects of the subject including crystallization of intermediates as well as final products. In addition, precipitations and amorphous solids will be covered and the differences between amorphous solids and crystalline solids will be discussed.

Royal Society of Chemistry (RSC)

The aim of the 8th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with this theme in having over three-quarters of the presentations focused on case studies. This will be complemented by technology progress in high concentration, NMR, SPR and X-ray screening.